| Lance A Rettig, MD | |
|
10767 Illinois St Ste 3000, Carmel, IN 46032-8972 | |
| (317) 817-1200 | |
| (317) 817-1220 |
| Full Name | Lance A Rettig |
|---|---|
| Gender | Male |
| Speciality | Hand Surgery |
| Experience | 27 Years |
| Location | 10767 Illinois St Ste 3000, Carmel, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205889276 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 01051568A (Indiana) | Secondary |
| 207XS0106X | Orthopaedic Surgery - Hand Surgery | 01051568A (Indiana) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Reconstructive Hand To Shoulder Of Indiana, Llc | 7719088806 | 7 |
| Thomas A Brady Sports Medicine Ctr | 5991609281 | 69 |
News Archive
The Hill: Leaders of the House Ways and Means Committee have offered a bipartisan bill to allow the Department of Health and Human Services to exclude corporate executives from Medicare if their companies were convicted of fraud. "The bill, introduced by Reps. Pete Stark (D-Calif.) and Wally Herger (R-Calif.), would also give the HHS Office of the Inspector General the ability to exclude parent companies that may be committing fraud through shell companies."
Emergent BioSolutions today announced that its facility in Lansing, Michigan has been recognized with the 2013 North American Maintenance Excellence Award by the Foundation for Industrial Maintenance Excellence.
ReachBio LLC announced today the launch of HemoRANK(TM)-TKI, an in vitro assay service package that helps predict the potential of novel therapeutic tyrosine kinase inhibitors (TKIs) to cause clinical hematotoxicity (myelotoxicity or neutropenia).
Gene therapy has shown promise for treating a neurodegenerative disease known as frontotemporal dementia and a related condition called neuronal ceroid lipofuscinosis, according to new findings presented in the Journal of Neuroscience by researchers from the University of Alabama at Birmingham.
› Verified 4 days ago
| Entity Name | Thomas A Brady Sports Medicine Ctr |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467484212 PECOS PAC ID: 5991609281 Enrollment ID: O20031119000777 |
News Archive
The Hill: Leaders of the House Ways and Means Committee have offered a bipartisan bill to allow the Department of Health and Human Services to exclude corporate executives from Medicare if their companies were convicted of fraud. "The bill, introduced by Reps. Pete Stark (D-Calif.) and Wally Herger (R-Calif.), would also give the HHS Office of the Inspector General the ability to exclude parent companies that may be committing fraud through shell companies."
Emergent BioSolutions today announced that its facility in Lansing, Michigan has been recognized with the 2013 North American Maintenance Excellence Award by the Foundation for Industrial Maintenance Excellence.
ReachBio LLC announced today the launch of HemoRANK(TM)-TKI, an in vitro assay service package that helps predict the potential of novel therapeutic tyrosine kinase inhibitors (TKIs) to cause clinical hematotoxicity (myelotoxicity or neutropenia).
Gene therapy has shown promise for treating a neurodegenerative disease known as frontotemporal dementia and a related condition called neuronal ceroid lipofuscinosis, according to new findings presented in the Journal of Neuroscience by researchers from the University of Alabama at Birmingham.
› Verified 4 days ago
| Entity Name | Reconstructive Hand To Shoulder Of Indiana, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003000399 PECOS PAC ID: 7719088806 Enrollment ID: O20070719000175 |
News Archive
The Hill: Leaders of the House Ways and Means Committee have offered a bipartisan bill to allow the Department of Health and Human Services to exclude corporate executives from Medicare if their companies were convicted of fraud. "The bill, introduced by Reps. Pete Stark (D-Calif.) and Wally Herger (R-Calif.), would also give the HHS Office of the Inspector General the ability to exclude parent companies that may be committing fraud through shell companies."
Emergent BioSolutions today announced that its facility in Lansing, Michigan has been recognized with the 2013 North American Maintenance Excellence Award by the Foundation for Industrial Maintenance Excellence.
ReachBio LLC announced today the launch of HemoRANK(TM)-TKI, an in vitro assay service package that helps predict the potential of novel therapeutic tyrosine kinase inhibitors (TKIs) to cause clinical hematotoxicity (myelotoxicity or neutropenia).
Gene therapy has shown promise for treating a neurodegenerative disease known as frontotemporal dementia and a related condition called neuronal ceroid lipofuscinosis, according to new findings presented in the Journal of Neuroscience by researchers from the University of Alabama at Birmingham.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Lance A Rettig, MD 10767 Illinois St Ste 3000, Carmel, IN 46032-8972 Ph: (317) 817-1200 | Lance A Rettig, MD 10767 Illinois St Ste 3000, Carmel, IN 46032-8972 Ph: (317) 817-1200 |
News Archive
The Hill: Leaders of the House Ways and Means Committee have offered a bipartisan bill to allow the Department of Health and Human Services to exclude corporate executives from Medicare if their companies were convicted of fraud. "The bill, introduced by Reps. Pete Stark (D-Calif.) and Wally Herger (R-Calif.), would also give the HHS Office of the Inspector General the ability to exclude parent companies that may be committing fraud through shell companies."
Emergent BioSolutions today announced that its facility in Lansing, Michigan has been recognized with the 2013 North American Maintenance Excellence Award by the Foundation for Industrial Maintenance Excellence.
ReachBio LLC announced today the launch of HemoRANK(TM)-TKI, an in vitro assay service package that helps predict the potential of novel therapeutic tyrosine kinase inhibitors (TKIs) to cause clinical hematotoxicity (myelotoxicity or neutropenia).
Gene therapy has shown promise for treating a neurodegenerative disease known as frontotemporal dementia and a related condition called neuronal ceroid lipofuscinosis, according to new findings presented in the Journal of Neuroscience by researchers from the University of Alabama at Birmingham.
› Verified 4 days ago
Dr. Stephen Peter Jacobsen, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 14535a Hazel Dell Pkwy, Carmel, IN 46033 Phone: 317-770-3777 Fax: 317-705-4391 | |
James W Hardacker, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 13431 Old Meridian St Ste 200, Carmel, IN 46032 Phone: 317-573-7733 Fax: 317-573-7739 | |
Joseph Dominic Maratt, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 10767 Illinois St Ste 3000, Carmel, IN 46032 Phone: 317-817-1200 Fax: 317-817-1220 | |
David A Porter, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 10767 Illinois St Ste 3000, Carmel, IN 46032 Phone: 317-817-1200 Fax: 317-817-1220 | |
Joseph Douglas Smucker, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 13225 N Meridian St, Carmel, IN 46032 Phone: 317-228-7000 Fax: 317-228-2321 | |
Dr. Melanie Sanders, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 10767 Illinois St Ste 3000, Carmel, IN 46032 Phone: 317-817-1200 Fax: 317-817-1220 |